Chemical Compound Review:
Pyrraline (2S)-2-amino-6-[2- (hydroxymethyl)-5...
Synonyms:
CHEBI:59973, AC1Q5QLY, CTK8D4821, AR-1H0664, AC1L3U7Y, ...
- Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. Miyata, S., Monnier, V. J. Clin. Invest. (1992)
- First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry. Odani, H., Shinzato, T., Matsumoto, Y., Takai, I., Nakai, S., Miwa, M., Iwayama, N., Amano, I., Maeda, K. Biochem. Biophys. Res. Commun. (1996)
- Structure of advanced Maillard reaction products and their pathological role. Monnier, V.M., Nagaraj, R.H., Portero-Otin, M., Glomb, M., Elgawish, A.H., Sell, D.R., Friedlander, M.A. Nephrol. Dial. Transplant. (1996)
- Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Castellani, R., Smith, M.A., Richey, P.L., Perry, G. Brain Res. (1996)
- Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V.M., Witztum, J.L., Kurokawa, K. J. Clin. Invest. (1997)
- Advanced glycation end product deposits in climatic droplet keratopathy. Kaji, Y., Nagai, R., Amano, S., Takazawa, Y., Fukayama, M., Oshika, T. The British journal of ophthalmology (2007)
- Aging of proteins: immunological detection of a glucose-derived pyrrole formed during maillard reaction in vivo. Hayase, F., Nagaraj, R.H., Miyata, S., Njoroge, F.G., Monnier, V.M. J. Biol. Chem. (1989)
- High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Tsukahara, H., Shibata, R., Ohta, N., Sato, S., Hiraoka, M., Ito, S., Noiri, E., Mayumi, M. Metab. Clin. Exp. (2003)
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.D., Stern, D., Sayre, L.M., Monnier, V.M., Perry, G. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes. Miyata, S., Liu, B.F., Shoda, H., Ohara, T., Yamada, H., Suzuki, K., Kasuga, M. J. Biol. Chem. (1997)
- Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Sakata, N., Uesugi, N., Takebayashi, S., Nagai, R., Jono, T., Horiuchi, S., Takeya, M., Itabe, H., Takano, T., Myint, T., Taniguchi, N. Cardiovasc. Res. (2001)
- Inhibitory effects of tenilsetam on the Maillard reaction. Shoda, H., Miyata, S., Liu, B.F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., Kasuga, M. Endocrinology (1997)
- Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Shibata, N., Nagai, R., Miyata, S., Jono, T., Horiuchi, S., Hirano, A., Kato, S., Sasaki, S., Asayama, K., Kobayashi, M. Acta Neuropathol. (2000)
- Inhibition of in vitro pyrraline formation by L-arginine and polyamines. Méndez, J.D., Leal, L.I. Biomed. Pharmacother. (2004)
- Effect of intraperitoneal administration of heparin on advanced glycation end-products in CAPD. Mizuiri, S., Miyata, S., Sakai, K., Kobayashi, M., Miyagi, M., Nakanishi, T., Liu, B.F., Kojima, H., Hasegawa, A. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. (1999)
- Identification of new heterocyclic nitrogen compounds from glucose-lysine and xylose-lysine maillard model systems. Bailey, R.G., Ames, J.M., Mann, J. J. Agric. Food Chem. (2000)
- Glycoxidative modification of AA amyloid deposits in renal tissue. Uesugi, N., Sakata, N., Nagai, R., Jono, T., Horiuchi, S., Takebayashi, S. Nephrol. Dial. Transplant. (2000)
- Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy. Aso, Y., Takanashi, K., Sekine, K., Yoshida, N., Takebayashi, K., Yoshihara, K., Inukai, T. J. Lab. Clin. Med. (2004)
- Effect of Maillard reaction products on protein digestion. Oste, R. Prog. Clin. Biol. Res. (1989)
- Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients. Portero-Otín, M., Pamplona, R., Bellmunt, M.J., Bergua, M., Prat, J. Eur. J. Clin. Invest. (1997)
- Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation. Smith, P.R., Somani, H.H., Thornalley, P.J., Benn, J., Sonksen, P.H. Clin. Sci. (1993)
- Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline. Foerster, A., Henle, T. Biochem. Soc. Trans. (2003)